HomeBIOTECHNOLOGY

BIOTECHNOLOGY

EndoClot ® SIA Receives FDA Clearance

EndoClot SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of polyps, adenomas, early-stage cancers, and other GI mucosal lesions.